MOTS-c MOTS-c is a mitochondria-derived peptide that plays a role in metabolic homeostasis
GLP-1 medications, in general, have demonstrated significant efficacy in weight management in obese and overweight patients
The compound is designated as a research chemical and is not approved for human therapeutic use by any regulatory agency
Topical protocol: Application: Thin layer to affected area Frequency: 1 to 2 times daily Duration: Until healing is complete or as directed Choosing the right administration route The optimal route depends on the therapeutic goal
Their metabolic health markers, such as blood sugar and cholesterol, also returned to levels similar to those before treatment.(3) Another drawback to taking GLP-1 medications is that while they promote weight loss, recently published research shows that approximately 15% to 60% of the loss comes from lean mass.(5, 6) This is very concerning, because preserving muscle mass is crucial for maintaining metabolic rate, overall health, and functionality as we age.(7) The Potential Solution: A Ketogenic Lifestyle A paper by researchers at Virta Health, published in February 2024, suggests that a ketogenic diet may help people maintain their weight loss after transitioning off GLP-1 medications.(8) The study compared two groups of type 2 diabetes patients following a ketogenic diet: one group continued GLP-1 therapy, and the other group stopped the medication
Rather than hoping a small percentage of the nutrient survives digestion, liposomal technology is engineered to ensure a higher concentration reaches the target
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
